Application 215962
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALBENAZINE | VALBENAZINE | CAPSULE;ORAL | 40MG | No | No |
| 002 | VALBENAZINE | VALBENAZINE | CAPSULE;ORAL | 80MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INGREZZA | VALBENAZINE | Neurocrine Biosciences, Inc. | 4c970164-cafb-421f-9eb5-c226ef0a3417 | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | VALBENAZINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73134 | ORIG | 2023-01-10 |